These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7642381)

  • 1. [The diagnostic value of antinuclear antibodies].
    Lukowsky A; Sönnichsen N; Sterry W
    Hautarzt; 1995 Jun; 46(6):388-93. PubMed ID: 7642381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.
    Velthuis PJ; Kater L; van der Tweel I; Meyling FG; Derksen RH; Hené RJ; van Geutselaar JA; Baart de la Faille H
    Ann Rheum Dis; 1990 Mar; 49(3):163-7. PubMed ID: 2181945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
    Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
    Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies in neurology and their clinical application.
    Sudheer P; Agarwal A; Vishnu VY
    QJM; 2023 Jun; 116(6):415-420. PubMed ID: 34865171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical importance of antinuclear antibodies].
    Dabelić N; Cikes N
    Lijec Vjesn; 1997; 119(8-9):236-42. PubMed ID: 9481891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
    Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
    J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases].
    Kiefer D; von Brunn M; Baraliakos X; Andreica I; Braun J
    Z Rheumatol; 2020 Oct; 79(8):749-754. PubMed ID: 31889213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies as molecular and diagnostic probes.
    Whittingham S; McNeilage LJ
    Mol Cell Probes; 1988 Sep; 2(3):169-79. PubMed ID: 3065632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of antinuclear antibodies in connective tissue diseases.
    Bombardieri S; Neri R; Tartarelli G; d'Ascanio A; Giovanelli L
    Scand J Rheumatol Suppl; 1987; 66():35-45. PubMed ID: 3502510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.
    de Almeida Brito F; Maria Elói Santos S; Aparecida Ferreira G; Pedrosa W; Gradisse J; Cristina Costa L; Pretti Figueiredo Neves S
    Am J Clin Pathol; 2016 Mar; 145(3):323-31. PubMed ID: 27124914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of unidentified precipitin lines (UPLs) in immune precipitation assays.
    Pajaro A; Nikoloutsopoulos T; Roberts-Thomson P
    Pathology; 2015 Jan; 47(1):62-7. PubMed ID: 25474508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibodies in interstitial lung disease: Prevalence and clinical significance.
    Ghrairi N; Aouadi S; Elhechmi YZ; Ben Saad S; Ben Ali I; Yalaoui S
    Tunis Med; 2019 Nov; 97(11):1240-1245. PubMed ID: 32173825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and sensitivity of antinuclear and anticytoplasmic antibodies in the diagnosis and follow-up of systemic diseases.
    Gioud M
    Clin Rheumatol; 1987 Jun; 6 Suppl 1():27-33. PubMed ID: 3497763
    [No Abstract]   [Full Text] [Related]  

  • 17. Basics in standardization and practical applications of immunofluorescent microscopy: standardization of antinuclear antibody tests.
    Beutner EH; Kumar V; Greenlee P
    Lab Res Methods Biol Med; 1983; 8():49-70. PubMed ID: 6358746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An immunoenzymatic technique for the detection of antinuclear antibodies].
    Meriche H; Meriche-Gadiri S; Ghaffor M; Abbadi MC
    Ann Biol Clin (Paris); 2000; 58(6):711-4. PubMed ID: 11098167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of antinuclear fluorescence patterns and titres to autoantibody prevalence.
    Mohan TC; Nadarajah M; Sng EH
    Ann Acad Med Singap; 1989 Jul; 18(4):339-44. PubMed ID: 2679335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
    Peene I; Meheus L; Veys EM; De Keyser F
    Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.